← Leaderboards
Richard B Silverman
Northwestern University
$24,563,202
Attributed
$28,132,085
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,132,085 · 10
By mechanism
R01$23,751,313 · 8
R35$2,333,649 · 1
T32$2,047,123 · 1
Top collaborators
- Pembe Hande Ozdinler8 shared
- William L Klein2 shared
Most similar at Northwestern University
Same institution · by research overlap
- Mitra J Hartmann$4,440,815
- William L Klein$7,573,106
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignStructureAlzheimer&AposIn VivoBrainNeuronsAnalogEnzymesBaseInhibitor/AntagonistPropertyPharmaceutical PreparationsCrystallographyNeurodegenerative DisordersToxic EffectS DiseaseDrug KineticsRattusIn VitroParkinson DiseaseNerve DegenerationAffectNitric Oxide SynthaseArginine
Grant awards (75)
Investigations of the protein aggregation inhibitor NU-9 and its derivatives: mode of action and impact on Alzheimerâs disease and related dementias$1,401,127
R01 · FY2025 · AG
New Inactivators of GABA Aminotransferase for Epilepsy and Neuropathic Pain$476,062
R01 · FY2025 · NS · contact PI
Ornithine Aminotransferase Inactivation, a New Approach for Treatment of Cancers$373,062
R01 · FY2025 · CA · contact PI
Investigations of the protein aggregation inhibitor NU-9 and its derivatives: mode of action and impact on Alzheimerâs disease and related dementias$1,536,774
R01 · FY2024 · AG
New Inactivators of GABA Aminotransferase for Epilepsy and Neuropathic Pain$462,561
R01 · FY2024 · NS · contact PI
Ornithine Aminotransferase Inactivation, a New Approach for Treatment of Cancers$355,543
R01 · FY2024 · CA · contact PI
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases$561,194
R01 · FY2023 · AG
New Inactivators of GABA Aminotransferase for Epilepsy and Neuropathic Pain$477,670
R01 · FY2023 · NS · contact PI
Selective inhibition of nitric oxide synthase for multiple indications$429,644
R35 · FY2023 · GM · contact PI
Ornithine Aminotransferase Inactivation, a New Approach for Treatment of Cancers$360,196
R01 · FY2023 · CA · contact PI
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases$609,584
R01 · FY2022 · AG
New Inactivators of GABA Aminotransferase for Epilepsy and Neuropathic Pain$478,473
R01 · FY2022 · NS · contact PI
Selective inhibition of nitric oxide synthase for multiple indications$429,644
R35 · FY2022 · GM · contact PI
Ornithine Aminotransferase Inactivation, a New Approach for Treatment of Cancers$358,047
R01 · FY2022 · CA · contact PI
New Inactivators of GABA Aminotransferase for Epilepsy and Neuropathic Pain$95,000
R01 · FY2022 · NS · contact PI
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases$622,539
R01 · FY2021 · AG
New Inactivators of GABA Aminotransferase for Epilepsy and Neuropathic Pain$508,471
R01 · FY2021 · NS · contact PI
Selective inhibition of nitric oxide synthase for multiple indications$430,064
R35 · FY2021 · GM · contact PI
Ornithine Aminotransferase Inactivation, a New Approach for Treatment of Cancers$412,090
R01 · FY2021 · CA · contact PI
Administrative Supplement - Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases$120,000
R01 · FY2021 · AG
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases$635,495
R01 · FY2020 · AG
New Inactivators of GABA Aminotransferase for Addiction and Epilepsy$481,364
R01 · FY2020 · DA · contact PI
Selective inhibition of nitric oxide synthase for multiple indications$442,429
R35 · FY2020 · GM · contact PI
Chemistry of Life Processes Predoctoral Training Program$289,234
T32 · FY2020 · GM · contact PI
Selective inhibition of nitric oxide synthase for multiple indications$249,352
R35 · FY2020 · GM · contact PI
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases$671,753
R01 · FY2019 · AG
New Inactivators of GABA Aminotransferase for Addiction and Epilepsy$481,364
R01 · FY2019 · DA · contact PI
Selective inhibition of nitric oxide synthase for multiple indications$352,516
R35 · FY2019 · GM · contact PI
Chemistry of Life Processes Predoctoral Training Program$285,968
T32 · FY2019 · GM · contact PI
New Inactivators of GABA Aminotransferase for Addiction and Epilepsy$481,364
R01 · FY2018 · DA · contact PI
Selective inhibition of nitric oxide synthase for multiple indications$416,731
R01 · FY2018 · GM · contact PI
Chemistry of Life Processes Predoctoral Training Program$282,780
T32 · FY2018 · GM · contact PI
New Inactivators of GABA Aminotransferase for Addiction and Epilepsy$486,322
R01 · FY2017 · DA · contact PI
Selective inhibition of nitric oxide synthase for multiple indications$421,538
R01 · FY2017 · GM · contact PI
Chemistry of Life Processes Predoctoral Training Program$279,669
T32 · FY2017 · GM · contact PI
New Inactivators of GABA Aminotransferase for Addiction and Epilepsy$503,656
R01 · FY2016 · DA · contact PI
Selective inhibition of nitric oxide synthase for multiple indications$422,806
R01 · FY2016 · GM · contact PI
Chemistry of Life Processes Predoctoral Training Program$276,636
T32 · FY2016 · GM · contact PI
Selective inhibition of nitric oxide synthase for multiple indications$502,671
R01 · FY2015 · GM · contact PI
New Inactivators of GABA Aminotransferase for Addiction$309,760
R01 · FY2015 · DA · contact PI
Chemistry of Life Processes Predoctoral Training Program$273,682
T32 · FY2015 · GM · contact PI
Selective Inhibition of Neuronal Nitric Oxide Synthase$402,370
R01 · FY2014 · GM · contact PI
New Inactivators of GABA Aminotransferase for Addiction$316,028
R01 · FY2014 · DA · contact PI
Chemistry of Life Processes Predoctoral Training Program$180,536
T32 · FY2014 · GM · contact PI
Selective Inhibition of Neuronal Nitric Oxide Synthase$387,171
R01 · FY2013 · GM · contact PI
New Inactivators of GABA Aminotransferase for Addiction$331,428
R01 · FY2013 · DA · contact PI
Chemistry of Life Processes Predoctoral Training Program$178,618
T32 · FY2013 · GM · contact PI
Selective Inhibition of Neuronal Nitric Oxide Synthase$370,767
R01 · FY2012 · GM · contact PI
New Inactivators of GABA Aminotransferase for Addiction$359,916
R01 · FY2012 · DA · contact PI
Selective Inhibition of Neuronal Nitric Oxide Synthase$420,034
R01 · FY2011 · GM · contact PI
New Inactivators of GABA Aminotransferase for Addiction$278,329
R01 · FY2011 · DA · contact PI
Selective Inhibition of Neuronal Nitric Oxide Synthase$287,768
R01 · FY2010 · GM · contact PI
Selective Inhibition of Neuronal Nitric Oxide Synthase$290,889
R01 · FY2009 · GM · contact PI
Selective Inhibition of Neuronal Nitric Oxide Synthase$163,485
R01 · FY2009 · GM · contact PI
Selective Inhibition of Neuronal Nitric Oxide Synthase$291,090
R01 · FY2008 · GM · contact PI
Celestrols for Treatment of Neurodegenerative Diseases$288,056
R01 · FY2007 · NS · contact PI
Selective Inhibition of Neuronal Nitric Oxide Synthase$287,302
R01 · FY2007 · GM · contact PI
Mechanism-Based & Structure-Based Inhibitors of GABA-AT$262,954
R01 · FY2007 · GM · contact PI
Celestrols for Treatment of Neurodegenerative Diseases$296,904
R01 · FY2006 · NS · contact PI
Mechanism-Based & Structure-Based Inhibitors of GABA-AT$270,807
R01 · FY2006 · GM · contact PI
Selective Inhibition of Neuronal Nitric Oxide Synthase$93,333
R01 · FY2006 · GM · contact PI
Celestrols for Treatment of Neurodegenerative Diseases$304,289
R01 · FY2005 · NS
Mechanism-Based &Structure-Based Inhibitors of GABA-AT$277,324
R01 · FY2005 · GM
Selective Inhibition of Neuronal Nitric Oxide Synthase$274,400
R01 · FY2005 · GM
Mechanism-Based &Structure-Based Inhibitors of GABA-AT$293,646
R01 · FY2004 · GM
Celestrols for Treatment of Neurodegenerative Diseases$288,365
R01 · FY2004 · NS
Selective Inhibition of Neuronal Nitric Oxide Synthase$274,400
R01 · FY2004 · GM
Selective Inhibition of Neuronal Nitric Oxide Synthase$274,400
R01 · FY2003 · GM
Selective Inhibition of Neuronal Nitric Oxide Synthase$14,061
R01 · FY2003 · GM
INACTIVATION, STRUCTURE, AND MECHANISM OF MAO$318,005
R01 · FY2002 · GM
MECHANISM &DESIGN OF NITRIC OXIDE SYNTHASE INACTIVATORS$4,160
R01 · FY2002 · GM
INACTIVATION, STRUCTURE, AND MECHANISM OF MAO$310,116
R01 · FY2001 · GM
MECHANISM &DESIGN OF NITRIC OXIDE SYNTHASE INACTIVATORS$198,314
R01 · FY2001 · GM
INACTIVATION, STRUCTURE, AND MECHANISM OF MAO$302,453
R01 · FY2000 · GM
MECHANISM &DESIGN OF NITRIC OXIDE SYNTHASE INACTIVATORS$195,532
R01 · FY2000 · GM